MediciNova Inc. (MNOV) announced after the close Tuesday the presentation of preliminary results from a Phase 1b study of MN-166 in methamphetamine addiction at the 75th Annual Meeting of the College on Problems of Drug Dependence in San Diego.
MediciNova spiked to the upside at the open Wednesday and is now higher by 0.93 at $3.50 on above average volume. The stock has surged to a 1-month high.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.